Phytotherapy postoperative complications in minimally invasive surgery for nephrolithiasis in patients with metabolic syndrome

##plugins.themes.bootstrap3.article.sidebar##

PDF (Українська)
Published: Oct 29, 2015
DOI: https://doi.org/10.30841/2307-5090.3(54).2015.105354
Keywords:
ureterolitiaz, metabolic syndrome, dyslipidemia, herbal medicine,

##plugins.themes.bootstrap3.article.main##

С. О. Возіанов
ДУ «Інститут урології НАМН України», м. Київ, Національна медична академія післядипломної освіти ім. П.Л. Шупика, м. Київ, Ukraine
А. Ю. Гурженко
Національна медична академія післядипломної освіти ім. П.Л. Шупика, м. Київ, Ukraine

Abstract

There were examined 71 patients with ureterolitiazom different localization and metabolic syndrome (MS) were divided into groups: I (n=41), where, after TUKL outpatient monotherapy administered herbal preparation Flavia® for 90-days and and II (n=30), which accounted for similar cases using traditional herbal medicine (diuretics charges). The results were compared with data III (n=35; ureterolitiazu cases in patients with no signs of MS and to the same treatment) and IV group (n=23; healthy volunteers). The median age was investigated 46,8±2,4 years, duration of MS history – 5,6±0,9 years. It has been found that the presence of the metabolic syndrome in patients with urolithiasis is a negative background for the formation in the early postoperative period is more than 19.7% and 18,5±0,4% represented hyperglycemia. It was found a significant correlation between the presence of acute calculous obstruction and high levels of glycemia, bacteriuria, urinary microalbumin and violations of lipid profile, which are interconnected with one another, and in proportion to the decrease in conducting appropriate tactics in the postoperative period. Shifts metabolic nature (hyperglycemia and dyslipidemia) correlate with increased urinary calcium indicators, uric acid and oxalic acid, which is reduced after the elimination of the obstruction and applying correction herbal preparation (Flavia®) for 90 days and more. Application of the combined herbal preparation (Flavia®) improves urinary parameters in patients with urolithiasis and associated metabolic syndrome, which results in reducing the amount of oxalate, uric acid and calcium.

##plugins.themes.bootstrap3.article.details##

How to Cite
Возіанов, С. О., & Гурженко, А. Ю. (2015). Phytotherapy postoperative complications in minimally invasive surgery for nephrolithiasis in patients with metabolic syndrome. Health of Man, (3(54), 55–62. https://doi.org/10.30841/2307-5090.3(54).2015.105354
Issue
No. 3(54) (2015)
Section
For practicing physicians
Copyright (c) 2020 С. О. Возіанов, А. Ю. Гурженко

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.

Author Biographies

С. О. Возіанов, ДУ «Інститут урології НАМН України», м. Київ, Національна медична академія післядипломної освіти ім. П.Л. Шупика, м. Київ

S. Vozianov

А. Ю. Гурженко, Національна медична академія післядипломної освіти ім. П.Л. Шупика, м. Київ

A. Gurzhenko

References

Березин А.Е. Концепция «пациента высокого кардиоваскулярного риска»: в центре внимания – сахарный диабет и метаболический синдром (обзор клинических рекомендаций)// Укр. мед. часопис. – 2007. – No 2 (58). – С. 20–23.

Берштейн Л.М., Коваленко И.Г. «Метаболически здоровые» лица с ожирением и метаболические признаки ожирения у лиц с нормальной массой тела: что за этим стоит // Проблемы эндокринологии. – 2010. – No 3. – С. 47–51.

Кайдашев И.П. Эволюция понятия «метаболический синдром» и его современное значение // Укр. мед. часопис. – 2012. – No 2 (88) III–IV. – С. 12–14.

Колпакова Т.А., Блинова В.В., Скворцов Ю.И., Субботина В.Г. Метаболический синдром Х – пандемия ХХІ века // Саратовский науч.-мед. журнал. – 2008. – No 3 (21). – С. 130–134.

Мамедов М.Н., Оганов Р.Г. Эпидемиологические аспекты метаболического синдрома // Кардиология. – 2004. – No 9. – С. 4–8.

Мітченко О.І., Корпачев В.В. Робоча група з проблем метаболічного синдрому, цукрового діабету, предіабету і серцево-судинних захворювань; Укр. асоціація кардіологів, Укр. асоціація ендокринологів. Діагностика і лікування метаболічного синдрому, цукрового діабету, предіабету і серцево-судинних захворювань: Метод. рекоменд. – Київ, 2009. – 42 с.

Cпиридоненко В.В., Гурженко А.Ю., Мороз О.Л. Метафілактика уролітіазу в осіб із єдиною ниркою після малоінвазивних втручань // Здоровье мужчины. – 2015. – No 2 (53). – С. 118–125.

Шестаев А.Ю., Паронников М.В., Протощак В.В., и соавт. Метафилактика оксалатного уролитиаза у больных с метаболическим синдромом // Эксперим. и клин. урология. – 2014. – No 3. – С. 123–127.

Abdourahman H., Desfemmes F.R., De Chaumont А. et al. Epidemiology of urinary stones in the French military during the operation Serval // Prog Urol. – 2014. – V. 24 (12). – P. 764–770.

Al-Mosawi A.J. Essential oil terpenes: adjunctive role in the management of childhood urolithiasis // J Med Food. 2010 Apr;13 (2):247–50.

Ali S.A., Rizk M.Z., Ibrahim N.A. et al. Protective role of Juniperus phoenicea and Cupressus sempervirens against CCl // World J.Gastrointest Pharmacol Ther. 2010. Dec 6; 1 (6):123–31.

Alberti K.G., Zimmet P., Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome – a new worldwide definition // Lancet. 2005. – V. 366 (9491). – P. 1059–1062.

Alberti K.G., Eckel R.H., Grundy S.M. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity // Circulation, 2009. 120(16): 1640–1645.

Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med.,1998. 15(7): 539–553.

Asgary S., Naderi G.A., Shams Ardekani M.R. et al. Inhibition of protein glycation by essential oils of branchlets and fruits of Juniperus communis subsp. Hemisphaerica // Res. Pharm. Sci. 2014. May-Jun; 9 (3): 179–85.

Azzimonti B., Cochis A., Beyrouthy M.E., et al. Essential Oil from Berries of Lebanese Juniperusexcelsa M. Bieb Displays Similar Antibacterial Activity to Chlorhexidine but Higher Cytocompatibility with Human Oral Primary // Cells. Molecules. – 2015 May21; 20 (5): 9344–57.

Bhaskaran N., Shukla S., Kanwal R., Srivastava J.K., Gupta S. Induction of heme oxygenase-1 by chamomile protects murine macrophages against oxidative stress // Life Sci. 2012. Jun 27; 90(25–26): 1027–33.

Bhaskaran N., Srivastava J.K., Shukla S., Gupta S. Chamomile confers protection against hydrogen peroxideinduced toxicity through activation of Nrf2-mediated defense response //Phytother Res. 2013. Jan; 27(1):118–25.

Borch-Johnsen K., Wareham N. The rise and fall of the metabolic syndrome. Diabetologia, 2010. 4 (53):597–599.

Carr D.B., Utzschneider K.M., Hull R.L. et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes, 2004. – 53(8): 2087–2094.

Cho S.T., Jung S.I., Myung S.C., Kim T.H. Correlation of metabolic syndrome with urinary stone composition // Int. J. of Urol. – 2013. – No 20. – Р. 208–213.

Chua ME, Park JH, Castillo JC, Morales ML Jr. Terpene compound drug as medical expulsive therapy for ureterolithiasis: a meta-analysis // Urolithiasis. 2013. – Apr; 41 (2):143–51.

Cheng H, Bo Y, Shen W, Tan J, Jia Z, Xu C, Li F. Leonurine ameliorates kidney fibrosis via suppressing TGF-β and NF-кB signaling pathway in UUO mice. Int Immunopharmacol. 2015. Apr; 25(2):406–15.

Cioanca O, Hancianu M, Mihasan M, Hritcu L. Anti-acetyl-cholinesterase and Antioxidant Activities of Inhaled Juniper Oil on Amyloid Beta (1–42) – Induced Oxidative Stress in the Rat Hippocampus // Neurochem. Res. 2015 May; 40 (5): 952–60.

De Fronzo R.A. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009 // Diabetologia, 53(7): 1270–1287.

DIAMAP Road Map for Diabetes Research in Europe. Road Map Report. September 2010, 198 p. (www.diamap.eu/report/DIAMAP-Road-Map-Report-Sept2010.pdf).

Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet, 2005. 365 (9468): 1415–1428.

Ekeruo W.O., Tan Y.H., Young M.O. et al. Metabolic risk factors and impact of medical therapy on the management of nephrolithiasis in obese patients // J. Urol. 2004: 172; P. 159–63.

Ford E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care, 2005. 28 (7): 1769–1778.

Hosseinzadeh H., Khooei A.R., Khashayarmanesh Z., Motamed-Shariaty V. Antiurolithiatic activity of Pinus eldarica medw: fruits aqueous extract in rats // Urol J. 2010 Fall;7 (4):232–7.

Haug K.G., Weber B., Hochhaus G., Butterweck V. Pharmacokinetic evaluation of visnagin and Ammi visnaga aqueous extract after oral administration in rats // Planta Med. 2012 Nov; 78 (17):1831–6.

McKay D.L., Blumberg J.B. A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.) // Phytother Res. 2006.Aug; 20(8):619–33.

N’gamba M., Lebdai S., Hasting C. et al. Acute renal colic during pregnancy: management and predictive factors // Can J Urol. 2015 Apr;22(2):7732–8.

Prezioso D., Illiano E, Piccinocchi G. Urolithiasis in Italy: an epidemiological study //Arch. Ital. Urol. Andr. – 2014. – V. 86 (2). – P. 99–102.

Schilcher H. Juniper berry oil in diseases of the efferent urinary tract? // Med Monatsschr Pharm. 1995. Jul;18(7):198–9.

Sela F., Karapandzova M., Stefkov G., Cvetkovikj I., Kulevanova S. Chemical composition and antimicrobial activity of essential oils of Juniperus excelsa Bieb.(Cupressaceae) grown in R. Macedonia //Pharmacognosy Res. – 2015. Jan-Mar; 7 (1): 74–80.

Shoag J., Halpern J., Goldfarb D.S., Eisner B.H. Risk of chronic and end stage kidney disease in patients with nephrolithiasis // J. Urol. – 2014. – V. 192 (5). – P. 1440–1445.

Simmons R.K., Alberti K.G., Gale E.A. et al. The metabolic syndrome: useful concept or clinical tool. Report of a WHO Expert Consultation // Diabetologia, 2010. 4(53): 600–605.

Srivastava J.K., Pandey M., Gupta S. Chamomile, a novel and selective COX-2 inhibitor with antiinflammatory activity // Life Sci. 2009. Nov 4; 85(19–20):663–9.

Stappen I., Tabanca N., Ali A. et al. Chemical Composition and Biological Activity of Essential Oils from Wild Growing Aromatic Plant Species of Skimmia laureola and Juniperus macropoda from Western Himalaya // Nat. Prod. Commun. – 2015 Jun; 10 (6): 1071–4.

Ulukanli Z., Karabörklü S., Bozok F., et al. Chemical composition, antimicrobial, insecticidal, phytotoxic and antioxidant activities of Mediterranean Pinus brutia and Pinus pinea resin essential oils // Chin. J. Nat. Med. 2014 Dec;12(12):901–10.

Vanachayangkul P., Byer K., Khan S., Butterweck V. An aqueous extract of Ammi visnaga fruits and its constituents khellin and visnagin prevent cell damage caused by oxalate in renal epithelial cells // Phytomedicine. 2010. Jul;17(8–9):653–8.

Wojtyniak K., Szymanski M., Matіawska I. Leonurus cardiaca L. (motherwort): a review of its phytochemistry and pharmacology // Phytother Res. 2013. Aug; 27(8):1115–20.